On August 7, 2024, Novo Nordisk released its financial report for the first half of 2024, with operating revenue of 133.4 billion Danish kroner (DKK), equivalent to 19.5 billion US dollars, a year-on-year increase of 24%; Net profit was 45.5 billion Danish kroner, equivalent to 6.65 billion US dollars, a year-on-year increase of 16%. Among them, the sales revenue of semaglutide is nearly 13 billion US dollars, just one step away from the throne of the drug king.
...
阅读全文